High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma-Reference-Cited by-同舟云学术

High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma

Published:2013-06-20 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Rancea Michaela¹,Monsef Ina¹,von Tresckow Bastian²,Engert Andreas¹,Skoetz Nicole¹

Affiliation:

1. University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924

2. University Hospital of Cologne; Department I of Internal Medicine; Cologne Germany 50931

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD009411.pub2/fullpdf

Reference73 articles.

1. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial;Linch;Lancet,1993

2. Long-term results of HD-R1: conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoetic stem cell transplantation in relapsed Hodgkin's disease [abstract];Schmitz;European Journal of Haematology,2004

3. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial;Schmitz;Lancet,2002

4. HD-R1: first results of a randomized trial comparing aggressive chemotherapy with high-dose therapy (HDT) and hematopoietic stem cell transplantation (HSCT) in patients with chemosensitive relapse of Hodgkin's disease (HD);Schmitz;Blood,1997

5. High-dose therapy (HDT) followed by hematopoietic stem cell transplantation (HSCT) for relapsed chemosensitive Hodgkin's disease (HD): final results of a randomized GHSG and EBMT trial (HD-R1) [abstract];Schmitz;Journal of Clinical Oncology,1999

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for successful dose optimization in oncology drug development: a practical guide;Journal of Biopharmaceutical Statistics;2024-08-11

2. Hodgkin’s lymphoma in adults – diagnosis and treatment;Family Medicine & Primary Care Review;2024

3. The optimal management of relapsed and refractory Hodgkin lymphoma: post–brentuximab and checkpoint inhibitor failure;Hematology;2023-12-08

4. Very late relapse in Hodgkin lymphoma: Characterizing an understudied population;Clinical Lymphoma Myeloma and Leukemia;2023-11

5. Bone marrow composition features and possibilities of tumor involvement diagnosing in patients with classic Hodgkin’s lymphoma;Oncohematology;2023-09-12